Serial Number | 97249545 |
Word Mark | CANCERTOOLS.ORG GLOBAL RESEARCH TOOLS COLLABORATIVE |
Filing Date | Wednesday, February 2, 2022 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, April 2, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, February 6, 2024 |
Description of Mark | The mark consists of a circular design consisting of two single-lined intertwined circles in a green, blue and purple gradient to the left of the wording "CANCERTOOLS.ORG" in large lettering and the wording "GLOBAL RESEARCH TOOLS COLLABORATIVE" in smaller lettering beneath "CANCERTOOLS.ORG". All of the featured wording is in black. The color white in the mark represents transparent areas and is not claimed as a feature of the mark. |
Goods and Services | Reagents and media for medical purposes; chemical reagents for medical purposes; biological reagents and media for medical purposes; reagents and media for microbiological analysis for medical purposes; reagents for in-vitro laboratory use for medical purposes; bacterial preparations for medical purposes; peptides for medical purposes, namely, treatment of cancer; protein arrays for medical diagnosis purposes; cell lines for medical purposes |
Indication of Colors claimed | The color(s) green, blue, purple and black is/are claimed as a feature of the mark. |
Goods and Services | Antibodies for research purposes; peptides for research purposes; protein arrays for research purposes |
Goods and Services | Licensing of intellectual property |
Disclaimer with Predetermined Text | "CANCER TOOLS.ORG" AND "GLOBAL RESEARCH TOOLS COLLABORATIVE" |
Goods and Services | Biomedical research services; scientific laboratory services; medical research in the field of oncology; advisory services relating to chemical reagents; advisory services relating to biological reagents; scientific laboratory services relating to the production of monoclonal antibodies; laboratory research in the field of gene expression |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 29, 2023 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 8, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 8, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 8, 2022 |
Primary Code | 045 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Cancer Research Technology Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | London E2O1JQ GB |
Party Name | Cancer Research Technology Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | London E2O1JQ GB |
Event Date | Event Description |
Tuesday, April 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, February 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 6, 2024 | PUBLISHED FOR OPPOSITION |
Wednesday, January 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Sunday, December 31, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Sunday, December 31, 2023 | EXAMINER'S AMENDMENT ENTERED |
Sunday, December 31, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Sunday, December 31, 2023 | EXAMINERS AMENDMENT E-MAILED |
Sunday, December 31, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Friday, December 29, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, December 29, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, December 29, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, October 24, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, October 24, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, October 24, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, September 28, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, September 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, September 28, 2023 | ASSIGNED TO LIE |
Tuesday, May 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, November 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, November 21, 2022 | NON-FINAL ACTION E-MAILED |
Monday, November 21, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, November 15, 2022 | ASSIGNED TO EXAMINER |
Wednesday, February 9, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, February 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, February 5, 2022 | NEW APPLICATION ENTERED |